As ADAR2 is the enzyme responsible for editing the Q/R sites in GRIA2 transcripts, these results suggested that defective ADAR2 activity could be the causal mechanism of the editing deficiency observed in patients with ALS. This evidence concerns the gene ADARB1 and amyotrophic lateral sclerosis.